These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 18519687)
1. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Ganesan K; Ivanova T; Wu Y; Rajasegaran V; Wu J; Lee MH; Yu K; Rha SY; Chung HC; Ylstra B; Meijer G; Lian KO; Grabsch H; Tan P Cancer Res; 2008 Jun; 68(11):4277-86. PubMed ID: 18519687 [TBL] [Abstract][Full Text] [Related]
2. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression. Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041 [TBL] [Abstract][Full Text] [Related]
4. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798 [TBL] [Abstract][Full Text] [Related]
5. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461 [TBL] [Abstract][Full Text] [Related]
6. Loss of beta-catenin expression in metastatic gastric cancer. Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245 [TBL] [Abstract][Full Text] [Related]
7. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120 [TBL] [Abstract][Full Text] [Related]
8. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756 [TBL] [Abstract][Full Text] [Related]
9. Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cheng XX; Wang ZC; Chen XY; Sun Y; Kong QY; Liu J; Li H Cancer Lett; 2005 Jun; 223(2):339-47. PubMed ID: 15896469 [TBL] [Abstract][Full Text] [Related]
10. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Lowy AM; Clements WM; Bishop J; Kong L; Bonney T; Sisco K; Aronow B; Fenoglio-Preiser C; Groden J Cancer Res; 2006 May; 66(9):4734-41. PubMed ID: 16651426 [TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296 [TBL] [Abstract][Full Text] [Related]
12. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer. Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662 [TBL] [Abstract][Full Text] [Related]
14. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296 [TBL] [Abstract][Full Text] [Related]
15. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related]
16. OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer. De Toni EN; Thieme SE; Herbst A; Behrens A; Stieber P; Jung A; Blum H; Göke B; Kolligs FT Clin Cancer Res; 2008 Aug; 14(15):4713-8. PubMed ID: 18676739 [TBL] [Abstract][Full Text] [Related]
17. Wnt pathway is involved in advanced gastric carcinoma. Zhang H; Xue Y Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344 [TBL] [Abstract][Full Text] [Related]
18. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells. Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834 [TBL] [Abstract][Full Text] [Related]
19. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Pendás-Franco N; García JM; Peña C; Valle N; Pálmer HG; Heinäniemi M; Carlberg C; Jiménez B; Bonilla F; Muñoz A; González-Sancho JM Oncogene; 2008 Jul; 27(32):4467-77. PubMed ID: 18408752 [TBL] [Abstract][Full Text] [Related]
20. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Ning X; Sun S; Hong L; Liang J; Liu L; Han S; Liu Z; Shi Y; Li Y; Gong W; Zhang S; Chen Y; Guo X; Cheng Y; Wu K; Fan D Mol Cancer Res; 2007 Dec; 5(12):1254-62. PubMed ID: 18171983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]